https://thescriptpad.com/articles/fda-approves-bepirovirsen-hibsago-chronic-hepatitis-b-functional-cure.htmlThe Script Paden2026-10-21T10:00:00-04:00FDA Approves Bepirovirsen for Chronic Hepatitis B. In Phase 3, 19 Percent Reached Functional Cure Off Treatment. https://thescriptpad.com/articles/aad-hs-foundation-first-joint-hidradenitis-suppurativa-guidelines-step-therapy.htmlThe Script Paden2026-10-21T09:50:00-04:00AAD and HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines. Step Therapy Is Named the Largest Barrier. https://thescriptpad.com/articles/fda-final-guidance-prescription-drug-apps-software-labeling.htmlThe Script Paden2026-10-21T09:40:00-04:00FDA Finalizes Guidance on Prescription Drug Apps. Some Apps Now Belong in the Prescribing Information. https://thescriptpad.com/articles/fda-approves-first-generic-climara-pro-weekly-hormone-patch.htmlThe Script Paden2026-10-21T09:30:00-04:00FDA Approves the First Generic of Climara Pro, a Once-Weekly Estradiol-Levonorgestrel Patch https://thescriptpad.com/articles/annals-model-hepatitis-b-birth-dose-change-chronic-infections.htmlThe Script Paden2026-10-20T10:10:00-04:00Ending the Universal Hepatitis B Birth Dose Would Raise Chronic Infections by 19 to 83 Percent, a New Model Projects https://thescriptpad.com/articles/fda-approves-dostarlimab-msi-h-dmmr-locally-advanced-rectal-cancer.htmlThe Script Paden2026-10-20T10:00:00-04:00FDA Approves Dostarlimab for MSI-H/dMMR Rectal Cancer. In AZUR-1, 47 Percent Had a Sustained Complete Response Without Surgery. https://thescriptpad.com/articles/pelican-trial-cardiac-index-guided-therapy-abdominal-surgery-jama.htmlThe Script Paden2026-10-20T09:55:00-04:00Personalized Cardiac Index Targets Did Not Cut Complications After Major Abdominal Surgery. A 90-Day Death Signal Calls for Caution. https://thescriptpad.com/articles/fda-approves-satralizumab-thyroid-eye-disease-at-home-injection.htmlThe Script Paden2026-10-20T09:50:00-04:00FDA Approves Satralizumab for Thyroid Eye Disease. One of Two Phase 3 Trials Missed Its Primary Endpoint. https://thescriptpad.com/articles/340b-rebate-model-delay-act-bipartisan-house-bill-jan-2027-pilot.htmlThe Script Paden2026-10-20T09:40:00-04:00A Bipartisan House Bill Would Delay the 340B Rebate Model. The Pilot Is Set to Start Jan. 1, 2027. https://thescriptpad.com/articles/nejm-icraki-intermittent-dialysis-not-noninferior-to-crrt-aki.htmlThe Script Paden2026-10-19T10:00:00-04:00Intermittent Dialysis Was Not Noninferior to Continuous Therapy in Critically Ill Patients With AKI. The Trial Stopped Early.